
Care Capital
Description
Care Capital, based in Princeton, New Jersey, is a specialized venture capital firm dedicated to fostering innovation within the life sciences and pharmaceutical sectors. Established in 1998, the firm has built a reputation for its deep industry expertise and strategic approach to investing in companies that are developing groundbreaking technologies and therapies. Care Capital's investment philosophy centers on identifying and supporting enterprises poised to address significant unmet medical needs, contributing to advancements in global healthcare.
The firm's investment strategy is flexible, allowing it to engage with companies across various stages of development, from nascent startups to more established entities. Care Capital typically deploys initial investments ranging from $5 million to $25 million per company, demonstrating a commitment to providing substantial capital to its portfolio firms. This initial funding is often complemented by subsequent follow-on investments, reflecting Care Capital's long-term partnership approach and belief in the sustained growth potential of its ventures. The firm manages over $500 million in capital, underscoring its significant financial capacity and established presence in the healthcare investment landscape.
Beyond financial backing, Care Capital distinguishes itself through its active engagement with portfolio companies. The firm leverages its extensive network of industry experts, scientific advisors, and strategic partners to provide invaluable operational guidance, market insights, and business development support. This hands-on approach aims to accelerate the development and commercialization of innovative solutions, helping companies navigate the complex regulatory and market challenges inherent in the life sciences industry.
Care Capital's commitment extends to cultivating a robust ecosystem where scientific breakthroughs can translate into tangible patient benefits. By focusing on areas such as biopharmaceuticals, medical devices, diagnostics, and healthcare services, the firm plays a crucial role in advancing the next generation of healthcare solutions. Its consistent track record and specialized focus position Care Capital as a key player in driving innovation and growth within the vital life sciences sector.
Investor Profile
Care Capital has backed more than 34 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 21% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Israel.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
- Typical check size: $5M – $25M.
Stage Focus
- Series B (32%)
- Series A (18%)
- Series C (15%)
- Series D (12%)
- Series Unknown (12%)
- Series E (6%)
- Debt Financing (3%)
- Private Equity (3%)
Country Focus
- United States (94%)
- United Kingdom (3%)
- Israel (3%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical Device
- Health Diagnostics
- Biopharma
- Women's
- Therapeutics
- Medical
- Clinical Trials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.